Lactose Intolerance Treatment Market Report 2025

The lactose intolerance treatment market size has grown strongly in recent years. It will grow from $32.4 billion in 2024 to $34.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased awareness, changing dietary patterns, global rise in lactose intolerance cases, growing healthcare infrastructure, consumer preferences for natural and alternative products, government investments.

The lactose intolerance treatment market size is expected to see strong growth in the next few years. It will grow to $46.76 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to continued research and development, increasing incidence rates, personalized medicine approaches, rising healthcare expenditure, globalization of dietary habits, patient-centric healthcare. Major trends in the forecast period include rising demand for dairy alternatives, technological advancements in diagnostic tools, development of enzyme supplements, nutraceuticals and functional foods, global awareness and education initiatives, expansion in emerging markets.

The anticipated growth of the lactose intolerance treatment market is driven by the increasing incidences of small intestine diseases. These diseases affect the digestive system, leading to persistent inflammation in the gastrointestinal tract. Lactose intolerance treatment is utilized to address small intestine disorders, containing lactose that is broken down by the enzyme lactase in the small intestine into simpler sugars such as glucose and galactose. For example, a report from the United European Gastroenterology (UEG) in October 2022 highlighted that over 300 million people in Europe suffer from digestive illnesses, translating to potential costs of $20 billion in 2021. The increasing prevalence of small intestine diseases is, therefore, a significant factor propelling the growth of the lactose intolerance treatment market.

The lactose intolerance treatment market is expected to benefit from the growing global population in the forecast period. As the world population expands and dietary habits shift, the number of people with lactose intolerance is increasing, which is driving the demand for effective treatments and management solutions. This demographic trend, along with increased awareness of lactose intolerance, is anticipated to stimulate innovation and investment in therapeutic options. For example, in January 2024, the United States Census Bureau, a U.S. government agency, projected that the global population will reach 8,019,876,189, representing a growth of 75,162,541 (0.95%) from the previous year. As a result, the rising population is expected to fuel demand in the lactose intolerance treatment market.

The lactose intolerance treatment market is further supported by the increasing global population. The expansion of the world population, coupled with evolving dietary patterns, has led to a higher number of individuals experiencing lactose intolerance. This demographic shift, along with increased awareness of lactose intolerance, is expected to stimulate innovation and investment in therapeutic solutions. As per the United Nations projections, the global population is estimated to reach 8.5 billion in 2030 and further increase to 9.7 billion in 2050. This growth in population will consequently drive the demand for lactose intolerance treatment in the market.

Technological advancements are a prominent trend in the lactose intolerance treatment market. Major companies are actively developing technological solutions to enhance their market positions. For instance, Nestlé introduced a versatile and cost-effective sugar reduction technology in July 2023, applicable across different product categories. This technology not only reduces sugar but can also be utilized to produce low lactose and skimmed milk-based products, contributing to the technological advancements in the lactose intolerance treatment market.

Innovative products, such as animal-free creams, are being introduced by major companies in the lactose intolerance treatment market to sustain their positions. Animal-free cream cheese, a plant-based alternative for individuals with lactose intolerance, has been launched by Modern Kitchen in February 2022. Utilizing precision fermentation technology, this dairy-free product is made from real dairy but is lactose-free, hormone-free, and cholesterol-free. This innovation aligns with the market's focus on introducing alternatives to traditional dairy products to meet the needs of lactose intolerant consumers.

Major companies operating in the lactose intolerance treatment market include Abbott Laboratories Inc., Macleods Pharmaceuticals Limited, Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated, Lupin Pharmaceuticals Inc., Nestlé S.A., Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Wockhardt Ltd., Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., DuPont Nutrition & Biosciences Inc., Kerry Group plc, Koninklijke DSM N.V., Solvay S.A., Chr. Hansen Holding A/S, Bio-Cat Inc.

North America was the largest region in the lactose intolerance treatment market in 2024. The regions covered in the lactose intolerance treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lactose intolerance treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Lactose intolerance treatment addresses a digestive disorder characterized by insufficient production of lactase, a natural enzyme in the body. This condition can lead to symptoms such as abdominal pain, flatulence, bloating, cramps, acidity, and diarrhea. The treatment involves substituting the deficient lactase enzyme.

Various methods are employed in lactose intolerance treatment, including food supplements, enzyme lactase supplements, probiotics, and others. Food supplements are designed to compensate for nutritional deficiencies, ensure the adequate intake of specific nutrients, or support particular physiological functions. The types of intolerance covered include primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance, and developmental lactose intolerance, with administration through oral and injectable methods. These treatments are utilized by hospitals, homecare services, specialty clinics, and other end users.

The lactose intolerance treatment market research report is one of a series of new reports that provides lactose intolerance treatment market statistics, including lactose intolerance treatment industry global market size, regional shares, competitors with lactose intolerance treatment market share, detailed lactose intolerance treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the lactose intolerance treatment industry. This lactose intolerance treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lactose intolerance treatment market consists of sales of lactase enzyme products, tablets and drops that contain lactase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.